IMMUNE PRIVILEGE TO MHC‐DISPARATE TUMOR GRAFTS IN THE ANTERIOR CHAMBER OF THE EYE: I. QUANTITATIVE ANALYSIS OF INTRAOCULAR TUMOR GROWTH AND THE CORRESPONDING DELAYED HYPERSENSITIVITY RESPONSE